Carmit Nadri-Shay
General Counsel bei ADVAXIS, INC.
Aktive Positionen von Carmit Nadri-Shay
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ADVAXIS, INC. | General Counsel | - | - |
| AYALA PHARMACEUTICALS, INC. | General Counsel | 01.01.2018 | - |
Karriereverlauf von Carmit Nadri-Shay
Ehemalige bekannte Positionen von Carmit Nadri-Shay
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Protalix Biotherapeutics Ltd.
 Protalix Biotherapeutics Ltd. BiotechnologyHealth Technology Part of Protalix Biotherapeutics, Inc., Protalix Biotherapeutics Ltd. is an Israeli company that develops a proprietary plant cell culture technology and innovative bioreactor system. The company is based in Karmiel, Israel. Protalix Biotherapeutics was acquired by Orthodontix, Inc. on January 03, 2007. | General Counsel | - | - |
| KAMADA LTD. | General Counsel | - | - |
Ausbildung von Carmit Nadri-Shay
| Ben-Gurion University of the Negev | Doctorate Degree |
Statistik
International
| Israel | 5 |
| Vereinigte Staaten | 2 |
Operativ
| General Counsel | 4 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| KAMADA LTD. | Health Technology |
| AYALA PHARMACEUTICALS, INC. | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
Protalix Biotherapeutics Ltd.
Protalix Biotherapeutics Ltd. BiotechnologyHealth Technology Part of Protalix Biotherapeutics, Inc., Protalix Biotherapeutics Ltd. is an Israeli company that develops a proprietary plant cell culture technology and innovative bioreactor system. The company is based in Karmiel, Israel. Protalix Biotherapeutics was acquired by Orthodontix, Inc. on January 03, 2007. | Health Technology |
Old Ayala, Inc.
 Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Old Ayala, Inc. operates as a clinical-stage oncology company. It focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Rehovot, Israel. | Health Technology |
- Börse
- Insiders
- Carmit Nadri-Shay
- Erfahrung
